Roxas City allowed to acquire anti-COVID pill
ROXAS City, Capiz – The Roxas City temporary treatment and monitoring facility (TTMF) is the first outside the National Capital Region to secure a Compassionate Special Permit from the Food and Drug Administration which allows the use of the COVID-19 anti-viral pill Molnupiravir. The CSP means that the TTMF can acquire Molnupiravir, the first oral
By Staff Writer
ROXAS City, Capiz – The Roxas City temporary treatment and monitoring facility (TTMF) is the first outside the National Capital Region to secure a Compassionate Special Permit from the Food and Drug Administration which allows the use of the COVID-19 anti-viral pill Molnupiravir.
The CSP means that the TTMF can acquire Molnupiravir, the first oral drug to manage mild to moderate COVID-19 cases.
Roxas City Mayor Ronnie Dadivas said the pill will help COVID patients avoid hospitalization and even death.
Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses, and is used to treat COVID-19 in those infected by SARS-CoV-2.
Article Information
Comments (0)
LEAVE A REPLY
No comments yet
Be the first to share your thoughts!
Related Articles
WHEN THE FUNDING STOPPED: How USAID’s collapse quietly dismantled years of environmental and media work in the Philippines
(This is a companion report to the cross-border investigation “How a campaign of ‘half-truths’ against USAID went global – and reached Asia.”) Victor Prodigo was three years into a five-year project when the money vanished. The veteran development consultant had spent more than two decades working on the ground
